Opens in a new tab
SHIP Insights

Statins and Absolute Risk: Who Benefits Most?

November 10, 2026
Clinician and patient reviewing cardiovascular risk estimates and statin treatment benefits, illustrating absolute risk and personalized decision-making.

Statins reduce cardiovascular events, but the size of the benefit depends heavily on baseline risk. Learn how to read absolute risk reduction, NNT, current 2026 treatment thresholds, and the evidence on harms.

Standard Membership Required

This article is available to Standard and Investment Members.
Join SHIP Membership to unlock deeper insights, practical guidance,
member-only articles, and exclusive resources across all four SHIP pillars.

Already a member? Sign in below to continue reading.

Join Standard Membership

Share:

Comments

Leave the first comment